Answer
Bullous pemphigoid has been reported in patients taking linagliptin, a component of Jentadueto (linagliptin + metformin), and Jentadueto should be discontinued if this condition is suspected.
Sources for this answer
- Jentadueto 2.5 mg/850 mg and 2.5 mg/1,000 mg film-coated tabletsBoehringer Ingelheim Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 24Document updated
Sources checked